| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |